After opening the day on the positive note, Indian share markets gave up the gains as the session progressed and ended the day lower.
Indian benchmark indices ended the Interim Budget Day trading session with modest losses amid lacklustre moves post the Budget 2025 proposals announced by finance minister Nirmala Sitharaman
At the closing bell, the BSE Sensex stood lower by 107 points (down 0.2%).
Meanwhile, the NSE Nifty closed lower by 28 points (down 0.1%).
Maruti Suzuki, Cipla and Eicher Motors were among the top gainers today.
L&T, Titan and JSW Steel on the other hand, were among the top losers today.
The GIFT Nifty ended at 21,749 down by 38 points.
Broader markets are trading on higher. The BSE Mid Cap is trading 0.4% lower and the BSE Small Cap index is trading 0.2% lower.
Sectoral indices are trading mixed, with socks in FMC sector, auto sector and sector witnessing most buying. Meanwhile, stocks in metal sector, telecom secto and realty sector witnessed selling pressure.
Shares of Colgate, JK Cement, Lupin hit their respective 52-week highs today.
Now track the biggest movers of the stock market using stocks to watch today section. This should help you keep updated with the latest developments...
The rupee is trading at 82.97 against the US$.
Gold prices for the latest contract on MCX are trading 0.2% lower at Rs 62,600 per 10 grams.
Meanwhile, silver prices are trading 1% lower at Rs 71,549 per 1 kg.
Speaking of stock markets, the general elections in India have always played a big role in deciding sentiment in the market.
This may be for right or wrong reasons but the fact can't be denied. Most people who have put their hard-earned money in stocks either as investment or speculation, will be interested in knowing how the elections will impact the market.
Which stocks or sectors will rise in anticipation of the results? Which ones will be on the back foot?
Tue in to the below video to know the stocks likely to benefit from the 2024 general elections.
In news from the pharma sector, shares of Aurobindo Pharma slipped 10% to Rs 1,035.5 on the BSE in Thursday's intra-day trade after it said the US drug regulator is inspecting its Unit-4 in Telangana.
The US FDA is inspecting Eugia-III (erstwhile unit IV), which is a formulation manufacturing facility of Eugia Pharma Specialities.
The inspection is under progress from 22 January 2024 and has not been concluded yet. Eugia Pharma is the company's injectables arm.
Aurobindo said as per the usual and standard practice after the inspection is concluded, the company intimates exchanges regarding the outcome, including the number of observations, if any, and the same will be followed for the ongoing inspection.
The company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded speciality pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.
The company has 25 manufacturing and packaging facilities and a product portfolio spread over 7 major therapeutic/product areas encompassing CNS, AntiRetroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic.
In 2023, the shares of the company have given multibagger returns of 149%.
For more, check out 5 Midcap Stocks that Could Turn into Largecaps in 2024.
Moving on, diagnostics player Dr Lal PathLabs on 1 February reported a 54% year-on-year rise in consolidated net profit at Rs 813 m for the third quarter of this financial year.
The company reported a profit of Rs 528 m in the same period last year. Revenue for the October-December quarter came in at Rs 5.4 bn, up 10.1% from the year-ago quarter numbers of Rs 4.9 bn.
The company's reported earnings before interest, taxes, depreciation and amortisation (EBITDA) stood at Rs 1.4 bn, up 24.5% from Rs 1.1 bn in the year-ago period. The EBITDA margin was at 26.1% against 23.1% in the year-ago period.
Moving on to news from the auto sector, two-wheeler automobile stocks remained a mixed bag, with the majority trading lower after the government reduced the budget allocation for the Faster Adoption and Manufacturing of (Hybrid and) Electric Vehicle (FAME) scheme by nearly 44% to Rs 26.7 bn for FY25, potentially hampering EV adoption in the country.
Shares of Bajaj Auto pared pre-budget gains of over 2% and were trading 0.1% higher at Rs 767. Hero Motocorp shares were down almost half a per cent to Rs 4,605, while TVS Motor Company was trading at Rs 1,997, down 0.2% from the previous close. Eicher Motors was the only stock that remained unaffected after its January sales impressed investors.
In FY24, the government allocated a revised estimate of nearly Rs 48.1 bn for FAME schemes, the government's budget allocation document published on 1 February showed.
In the previous Budget, the allocation had seen a sizeable increase of 78% year-on-year. The 2023 allocation accounted for 85% of the total allocation made for the Ministry of Heavy Industries.
Before the FM's announcement, media reports had suggested that the Budget may set aside Rs 100-120 bn for FAME-III.
The reports quoted an anonymous ministry official who said that the focus of FAME-III would be on mass transport and personal mobility with two-wheelers, while also encouraging the use of alternative fuels such as hydrogen-powered vehicles.
The reports suggested that the government planned to replace 0.8 m diesel buses with electric ones by 2030, including 0.2 m buses running for the state transport service. That is a massive increase from the 4,000 electric buses currently plying on the Indian roads.
To know what's moving the Indian stock markets today, check out the most recent share market updates here.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Sensex Today Ends 107 Points Lower | Paytm Tanks 20% | L&T, Titan Top Losers". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!